Clinicopathological characteristics and prognosis of diffuse large B-cell lymphoma in relation to CA-125 and CA 19-9 expression
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
[HTML][HTML] Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
T Atia, HI Sakr, KAEA Elnaghi… - Journal of Evidence …, 2023 - ncbi.nlm.nih.gov
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
T Atia, HI Sakr, KAEA Elnaghi… - … of evidence-based …, 2023 - pubmed.ncbi.nlm.nih.gov
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
[PDF][PDF] Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
MD Abd AlRahman Mohammad Foda… - Journal of Evidence …, 2023 - researchgate.net
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 andCA19-9Expression.
AARM Foda, T Atia, HI Sakr… - Journal of Evidence …, 2023 - search.ebscohost.com
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) andCA19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) andCA19-9, especially ovarian and pancreatic tumors. Patients with non …
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.
AAM Foda, T Atia, HI Sakr… - Journal of Evidence …, 2023 - europepmc.org
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
[引用][C] Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
MD Abd AlRahman Mohammad Foda… - Journal of Evidence …, 2023 - europepmc.org
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.
AARM Foda, T Atia, HI Sakr… - Journal of Evidence …, 2023 - search.ebscohost.com
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …